Crispin R Dass
School of Biomedical and Health Sciences
Crispin R. Dass [(BAppSci (Hons), PhD)] has 17 years of cell and molecular biology research experience, mainly focusing on oncological R&D. He completed his secondary education in California, before moving to Australia for his tertiary education. His research is on systems at various levels-in silico, in vitro, in vivo, ADME/Tox, clinical, and also in biomedical education fostering passion in young scientists. His forte lies in formulation of nanoparticulate drug delivery systems for new and old compounds for cancer therapy. He has worked on projects for Johnson & Johnson, GlaxoSmithKline, Amgen, and Novartis. His extensive experience is documented in his 120 papers to date, with publications in Nature Medicine, Journal of the National Cancer Institute, Biomaterials, Nucleic Acids Research, Cancer, and Journal of Controlled Release. He is currently on the editorial board of 4 other journals in his field, and has been invited to chair sessions and to give keynote lectures at national and international conferences. Based currently in St Albans (Melbourne, Australia), he has research links within Australia and in Thailand, Fiji, USA, China, South Korea, Japan, Iran and India.
Cancer R & D
Drug delivery systems
Biomining for safer therapeutics